title: Polymorphisms in neuropsychiatric and neuroinflammatory disorders and the role of next generation sequencing in early diagnosis and treatment.
abstract: A number of polymorphisms have been implicated in different neuropsychiatric and neurological disorders. Polymorphisms in neurological disorders with a central immune component are well described, mainly due to their role in increasing neurodegeneration. For example, the role of polymorphisms in Alzheimer's disease in accumulation of amyloid plaques is now well established. In contrast, polymorphisms resulting in or affecting psychiatric disorders are less well studied and frequently are not replicated by meta-analysis. Furthermore, even if a significant association has been confirmed, the role of the identified polymorphism in causing and/or augmenting the disorder is often difficult to rationalize. Here, we review polymorphisms found associated with different neuroinflammatory and neuropsychiatric disorders and discuss the role of next generation sequencing in early diagnosis and treatment and as a tool in studying their functional consequences.
authors.affiliation: Institute of Life Science, College of Medicine, Swansea University, Swansea, UK. R.M.Donev@swansea.ac.uk
authors.forename: Rossen M
authors.initials: RM
authors.lastname: Donev
authors.forename: Owain W
authors.initials: OW
authors.lastname: Howell
mesh_terms: D042241:Early Diagnosis; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*; D019636:Neurodegenerative Diseases / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*